Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib Capsule
Clinical trial NCT04768985 · COMPLETED
Trial details
- NCT number
- NCT04768985
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-05-10
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.